Search   
MSDS  : 2-Naphthylamine, N,N-bis(2-chloroethyl)-
CAS  : 494-03-1
SYNONYMS  : * N,N-Bis-(2-chlorethyl)-2-naftylamin * 2-Bis(2-chloroethyl)aminonaphthalene * N,N,-Bis(2-chloroethyl)-2-naphthylamine * Bis(2-chloroethyl)-beta-naphthylamine * Chlornaftina * Chlornaphazin * Chlornaphazine * Chlornaphthin * Chloronaftina * Chloronaphthine * Dichloroethyl-beta-naphthylamine * Di(2-chloroethyl)-beta-naphthylamine * N,N-Di(2-chloroethyl)-beta-naphthylamine * 2-N,N-Di(2-chloroethyl)naphthylamine * Erysan * Naphthylamine mustard * beta-Naphthyl-bis-(beta-chloroethyl)amine * 2-Naphthylbis(2-chloroethyl)amine * beta-Naphthyl-di-(2-chloroethyl)amine * NSC-62209 * R48 * RCRA waste number U026
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : QM2450000
CHEMICAL NAME : 2-Naphthylamine, N,N-bis(2-chloroethyl)-
CAS REGISTRY NUMBER : 494-03-1
BEILSTEIN REFERENCE NO. : 3316600
REFERENCE : 4-12-00-03126 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 21
MOLECULAR FORMULA : C14-H15-Cl2-N
MOLECULAR WEIGHT : 268.20
WISWESSER LINE NOTATION : L66J CN2G2G
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
Human
SYNONYMS/TRADE NAMES :
* N,N-Bis-(2-chlorethyl)-2-naftylamin
* 2-Bis(2-chloroethyl)aminonaphthalene
* N,N,-Bis(2-chloroethyl)-2-naphthylamine
* Bis(2-chloroethyl)-beta-naphthylamine
* Chlornaftina
* Chlornaphazin
* Chlornaphazine
* Chlornaphthin
* Chloronaftina
* Chloronaphthine
* Dichloroethyl-beta-naphthylamine
* Di(2-chloroethyl)-beta-naphthylamine
* N,N-Di(2-chloroethyl)-beta-naphthylamine
* 2-N,N-Di(2-chloroethyl)naphthylamine
* Erysan
* Naphthylamine mustard
* beta-Naphthyl-bis-(beta-chloroethyl)amine
* 2-Naphthylbis(2-chloroethyl)amine
* beta-Naphthyl-di-(2-chloroethyl)amine
* NSC-62209
* R48
* RCRA waste number U026

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1086 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
13,969,1964

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ONRAAQ Oncologia si Radiologia. (Bucharest, Romania) V.1-13(3), 1962-74.
For publisher information, see ONCODU. Volume(issue)/page/year: 5,443,1966

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 2468 mg/kg/6Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
AMSVAZ Acta Medica Scandinavica. (Almqvist & Wiksell, POB 45150, S-10430
Stockholm, Sweden) V.52-224, 1919-88. Volume(issue)/page/year: 176,45,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 3132 mg/kg/10Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
AMSVAZ Acta Medica Scandinavica. (Almqvist & Wiksell, POB 45150, S-10430
Stockholm, Sweden) V.52-224, 1919-88. Volume(issue)/page/year: 176,45,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Unreported
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 3200 mg/kg/11Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
AMSVAZ Acta Medica Scandinavica. (Almqvist & Wiksell, POB 45150, S-10430
Stockholm, Sweden) V.52-224, 1919-88. Volume(issue)/page/year: 175,721,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 330 mg/kg/4W
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
36,915,1966

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 4090 mg/kg/7Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
AMSVAZ Acta Medica Scandinavica. (Almqvist & Wiksell, POB 45150, S-10430
Stockholm, Sweden) V.52-224, 1919-88. Volume(issue)/page/year: 176,45,1964

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 3200 mg/kg/11Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
AMSVAZ Acta Medica Scandinavica. (Almqvist & Wiksell, POB 45150, S-10430
Stockholm, Sweden) V.52-224, 1919-88. Volume(issue)/page/year: 185,133,1969

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 20 ug/plate
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
37,2209,1977

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 10 ug/plate
REFERENCE :
PNASA6 Proceedings of the National Academy of Sciences of the United States
of America. (National Academy of Sciences, Printing & Pub. Office, 2101
Constitution Ave., Washington, DC 20418) V.1- 1915-
Volume(issue)/page/year: 72,5135,1975

TYPE OF TEST : Specific locus test
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Insect - Drosophila melanogaster
DOSE/DURATION : 2600 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
30,195,1970

TYPE OF TEST : Sex chromosome loss and nondisjunction
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Insect - Drosophila melanogaster
DOSE/DURATION : 2600 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
30,195,1970

TYPE OF TEST : Morphological transformation
TEST SYSTEM : Rodent - hamster Embryo
DOSE/DURATION : 120 ug/L
REFERENCE :
AETODY Advances in Modern Environmental Toxicology. (Senate Press, Inc.,
P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980-
Volume(issue)/page/year: 1,241,1980

*** REVIEWS ***

IARC Cancer Review:Human Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 4,119,1974

IARC Cancer Review:Animal Limited Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 4,119,1974

IARC Cancer Review:Group 1
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,130,1987

TOXICOLOGY REVIEW
ADCSAJ Advances in Chemistry Series. (American Chemical Soc., Distribution
Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1-
1950- Volume(issue)/page/year: 13,271,1970

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE; Histidine
reversion-Ames test

EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal

EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat

Deleted from 6th Annual Report. reason: no U.S. residents exposed


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Naphtho(1,2-b)thiopyrylium,5,6-dihydro-2,4-diphenyl-, iodide 65193-68-2
Naphtho(1,2-b)thiopyrylium,5,6-dihydro-2,4-diphenyl-, perchlorate 65193-67-1
Naphtho(1,2-b)thiopyrylium, 5,6-dihydro-2,4-diphenyl-trifluoroacetate 65193-67-1
Naphtho(1,2-b)thiopyrylium,5,6-dihydro-2,4-diphenyl-, salt with trifluoroaceticacid (1:1) 65193-66-0
Naphtho(1,2-b)thiopyrylium,5,6-dihydro-2-(p-methoxyphenyl)-4-phenyl-,trifluoroacetate 65193-66-0
Naphtho(1,2-b)thiopyrylium,5,6-dihydro-4-(p-methoxyphenyl)-2-phenyl-,trifluoroacetate 65193-66-0
1H-Naphtho(2,3-d)triazole-4,9-dione, 6,7-dimethyl- 72364-91-1
2H-Naphtho(1,2-d)triazole-6,8-disulfonic acid,2-(4'-amino-1,1'-biphenyl-4-yl)-, dipotassium salt 74039-01-3
2H-Naphtho(1,2-d)triazole-6,8-disulfonic acid,2-(4'-amino-3'-sulfo-1,1'-biphenyl-4-yl)-,tripotassium salt 74039-02-4
3H-Naphtho(1,2-d)triazolium, 1,3-dimethyl-, chloride 74039-02-4
1-Naphthoic acid, 1,4-dihydro-, 2-(diethylamino)ethylester, hydrochloride 67293-09-8
3H-Naphtho(1,2-d)triazolium, 2,3-dimethyl-, chloride 67293-09-8
3H-Naphtho(1,2-d)triazolium, 1,3-dimethyl-, iodide 67293-09-8
3H-Naphtho(1,2-d)triazolium, 2,3-dimethyl-, iodide 67293-09-8
3H-Naphtho(1,2-d)triazolium, 2,3-diphenyl-, chloride 67293-09-8
2H-Naphth(1,2-b)-1,5-oxazocin-3-ol,3,4-dihydro-6-methyl- 27827-70-9
Naphth(1,2-b)oxirene-2,3-diol, 1a,2,3,7b-tetrahydro-,(1a-alpha,2-alpha,3-beta,7b-alpha)- 69222-27-1
Naphth(1,2-b)oxirene-2,3-diol, 1a,2,3,7b-tetrahydro-,(1a-alpha,2-beta,3-alpha,7b-alpha)- 69222-28-2
Naphth(2,3-b)oxirene-2,7-dione,7a-(3,7-dimethyl-2,6-octadienyl)-1a,7a-dihydro-3,5-dihydroxy- 4-methyl-1a-(3-methyl-2-butenyl)-,(1a-alpha,7a-alpha(E))-(+)- 110200-30-1
Naphth(2,3-b)oxirene-2,4,7(3H)-trione,1a,7a-dihydro-3-diazo-1a-(3,7-dimethyl-2,6-octadienyl)-6-hydroxy-5-methyl- 7a-(3-methyl-2-butenyl)-,(1a-alpha(E),7a-alpha)-(+)- 110200-31-2
Naphth(1,2-b)oxiren-2(1ah)-one,4,5,6,7,7a,7b-hexahydro-7,7a-dimethyl-6-hydroxy-1a-(2-(hydroxymethyl)oxiranyl)- 85431-61-4
1-Naphthoic acid, 2,3-dihydroxy- 16715-77-8
1-Naphthylamine 134-32-7
2-Naphthylamine 91-59-8
1-Naphthylamine, acetate 91-59-8
2-Naphthylamine, N-(L-alanyl)-1,2,3,4-tetrahydro- 14329-69-2
1-Naphthylamine, N-(5-amino-2-oxazolyl)- 102280-40-0
2-Naphthylamine, N,N-bis(2-chloroethyl)- 494-03-1
1-Naphthylamine,N,N-bis(2-chloroethyl)-4-methoxy-3-methyl- 17692-54-5
1-Naphthylamine, 2-bromo-N-(2-imidazolin-2-yl)-,hydrobromide 102280-41-1
1-Naphthylamine, 4-bromo-N-(2-imidazolin-2-yl)-,hydrochloride 102280-42-2
1-Naphthylamine,4-chloro-N-(5,6-dihydro-4H-1,3-thiazin-2-yl)- 102280-43-3
1-Naphthoic acid, 2-(dimethylamino)ethyl ester,hydrochloride 50310-44-6
1-Naphthylamine, decahydro-N-(2-oxazolin-2-yl)- 100531-21-3
1-Naphthylamine, 2,4-dibromo-N-(2-imidazoline-2-yl)-,hydrobromide 102280-44-4
1-Naphthylamine, 5,8-dichloro- 3604-99-7
2-Naphthylamine, 5,6-dimethoxy- 23922-96-5
2-Naphthylamine, 5,6-dimethoxy-N,N-dimethyl- 23923-03-7
2-Naphthylamine, 5,6-dimethoxy-N-methyl- 23923-00-4
1-Naphthylamine, N,N-dimethyl- 86-56-6
2-Naphtylamine, mixed with(alpha,alpha-dimethylbenzyl)hydroperoxide 86-56-6
2-Naphthylamine,N-ethyl-1-((p-(phenylazo)phenyl)azo)- 6368-72-5
2-Naphthylamine, N-ethyl-1,2,3,4-tetrahydro- 19485-86-0
Naphtho(2,3-b)furan, 5,6,7,8-tetrahydro-2-nitro- 86295-47-8
2-Naphthoic acid, 3-ethoxy-, 3-(diethylamino)propylester, hydrochloride 110331-08-3
2-Naphthylamine,N-(2-fluoroethyl)-N-(2-methoxyethyl)- 15314-55-3
1-Naphthylamine hydrochloride 552-46-5
2-Naphthylamine, hydrochloride 612-52-2
1-Naphthylamine, N-(2-imidazolin-2-yl)- 4751-46-6
2-Naphthylamine, 1-methoxy- 3178-03-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net